Korstiaan Eric Van Wyngaarden MD
Global Director Online at Philips (Healthcare)
Amsterdam, The Netherlands
Professional summary
Specialties and Interests
-
Radiology
Education
Universities
Leiden University
MSc, MD
1996
Postgraduate Training
NYIT
2004 to 2006
MBA
Publications
Articles
"Radiolabelled antimicrobial peptides for imaging of infections: a review."
Nuclear medicine communications
Vol. 19 -
1999;
PubMed ID: 9885800
"Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue?"
Thyroid : official journal of the American Thyroid Association
Vol. 7 -
1997;
PubMed ID: 9226201
"Fluorodeoxyglucose (FDG) and tumour metabolism."
Nuclear medicine communications
Vol. 16 -
1996;
PubMed ID: 8719978
"What is the role of 1100 MBq (< 30 mCi) radioiodine 131I in the treatment of patients with differentiated thyroid cancer?"
Nuclear medicine communications
Vol. 17 -
1996;
PubMed ID: 8692486
"Hormesis: are low doses of ionizing radiation harmful or beneficial?"
European journal of nuclear medicine
Vol. 22 -
1995;
PubMed ID: 7641758
Disclosure or Conflict of Interest
Korstiaan Eric Van Wyngaarden MD has nothing to disclose
Tokens of Appreciation
A Token of Appreciation is a way of acknowledging another member for their contributions to Medpedia. You have 5 Tokens to give per week.